2024 # HCPR26 Heart Failure (HF): SGLT-2 Inhibitor Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Measure Title: Heart Failure (HF): SGLT-2 Inhibitor Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Description: Percentage of Patients Aged 18 years and Older with a Diagnosis of Heart Failure (HF) With a Current or Prior Left Ventricular Ejection Fraction (LVEF) Less Than or Equal to 40% Who Were Prescribed SGLT-2 Inhibitor Therapy at Hospital Discharge.

Denominator: Any patient greater than or equal to 18 years of age with a diagnosis of heart failure with a current or prior LVEF less than or equal to 40% evaluated by the Eligible Professional (Transferred, eloped, AMA or expired patients are excluded).

Denominator Criteria (Eligible Cases):

None

Numerator: Patients who were prescribed SGLT-2 inhibitor at time of hospital discharge.

Denominator Exclusions:

None

Denominator Exceptions: Documented medical reason for not prescribing SGLT-2 inhibitor (e.g., allergy, intolerance, fungal infection, renal failure, DKA).

National Quality Forum (NQF) number, if applicable

N/A

Care setting(s)
Hospital, Hospital Inpatient

Telehealth, if applicable
Yes

Number of performance rates required for measures
1

Traditional vs. inverse measure
Traditional

Proportional, continuous variable, and/or ratio measure indicator
Proportional

Risk adjustment, if applicable
No

Submission pathway
Traditional MIPS